Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Dec;21(1):2503602.
doi: 10.1080/21645515.2025.2503602. Epub 2025 May 15.

Pneumococcal vaccine hyporesponsiveness in people living with HIV: A narrative review of immunological mechanisms and insights from minimally invasive lymph node sampling

Giovanni E Loe-Sack-Sioe  1 , Danny W de Vos  2 , Leo G Visser  2 , Simon P Jochems  1 , Anna H E Roukens  2
Affiliations
Review

Pneumococcal vaccine hyporesponsiveness in people living with HIV: A narrative review of immunological mechanisms and insights from minimally invasive lymph node sampling

Giovanni E Loe-Sack-Sioe et al. Hum Vaccin Immunother. 2025 Dec.

Abstract

Despite highly effective antiretroviral therapy, people living with HIV (PLWH) remain at elevated risk for invasive pneumococcal disease. Clinical studies show that, even with high CD4+ counts, PLWH exhibit diminished serological responses and rapid antibody decline following pneumococcal vaccination, plausibly due to underlying immune dysfunction. Germinal centers (GCs), located within lymph nodes, are essential for generating high-affinity antibodies, but are structurally and functionally disrupted in PLWH. These local impairments, combined with systemic immune dysregulation, contribute to vaccine hyporesponsiveness in PLWH. This narrative review links immunological findings from experimental and in vivo studies to clinical pneumococcal vaccine trials, to investigate mechanisms that may be leveraged to strengthen vaccine-induced immunity in PLWH. We also highlight the application of fine needle aspiration (FNA) of the lymph node as a way to study pneumococcal vaccine hyporesponsiveness in the GC and provide potential direction to improve responses for next-generation pneumococcal conjugate vaccines in PLWH.

Keywords: Pneumococcal vaccination; germinal centers; lymph node fine-needle aspiration; people living with HIV; pneumococcal conjugate vaccine; pneumococcal polysaccharide vaccine.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Differences in T cell-dependent (PCV) vs T cell-independent (PPV) pneumococcal vaccine responses in humans. This figure was created using BioRender software.
Figure 2.
Figure 2.
Schematic overview of GC formation. 1) Early GC formation and clonal expansion occurring within weeks after initial contact with antigens. 2) Somatic hypermutation in the dark zone. 3) Selection in the light zone, B cells move into the light zone, where their modified B cell receptors are tested for improved antigen binding with help from Tfh cells and follicular dendritic cells. B cells with higher BCR affinity capture more antigen, receiving more T cell help, resulting in positive selection. B cells with unfavorable BCRs undergo apoptosis. 4) Recirculation and further mutation. Positively selected B cells undergo immunoglobulin class-switch recombination and are instructed to recirculate to the dark zone. In the dark zone, these B cells proliferate and undergo further SHM, generating higher affinity antibodies. 5) Final differentiation: antigen-selected B cells differentiate into memory B cell precursor cells and plasmablasts. This figure was created using BioRender software.
Figure 3.
Figure 3.
Schematic overview of germinal center changes in PLWH. FDC = follicular dendritic cells. Tregs = T follicular regulatory cells. Tfh = T follicular helper cells. Bgc = germinal center B cells. This figure was created using BioRender software.
Figure 4.
Figure 4.
GC and non-GC related immunological alterations in PLWH affecting vaccine responses. This figure was created using BioRender software.
Figure 5.
Figure 5.
Detailed lymph node fine-needle aspiration procedure. This figure was created using BioRender software.
See this image and copyright information in PMC

References

    1. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):868–17. doi: 10.1126/science.6189183. - DOI - PubMed
    1. Greene WC. A history of AIDS: looking back to see ahead. Eur J Immunol. 2007;37(Suppl 1):S94–102. doi: 10.1002/eji.200737441. - DOI - PubMed
    1. Wong CS, Buckner CM, Lage SL, Pei L, Assis FL, Dahlstrom EW, Anzick SL, Virtaneva K, Rupert A, Davis JL, et al. Rapid emergence of T follicular helper and germinal center B cells following antiretroviral therapy in advanced HIV disease. Front Immunol. 2021;12:752782. doi: 10.3389/fimmu.2021.752782. - DOI - PMC - PubMed
    1. Payagala S, Pozniak A. The global burden of HIV. Clin Dermatol. 2024;42(2):119–127. doi: 10.1016/j.clindermatol.2024.02.001. - DOI - PubMed
    1. Organization WH. Epidemiological fact sheet: HIV statistics, globally and by WHO region, 2023. World Health Organ. 2023.

MeSH terms

Substances